Luliconazole
Clinical data | |
---|---|
Trade names | Luzu, Lulicon |
Routes of administration | Topical |
ATC code | D01AC18 (WHO) |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | >99%[1] |
Identifiers | |
| |
CAS Number | 187164-19-8 |
PubChem (CID) | 3003141 |
ChemSpider | 2273807 |
Chemical and physical data | |
Formula | C14H9Cl2N3S2 |
Molar mass | 354.28 g/mol |
3D model (Jmol) | Interactive image |
| |
|
Luliconazole (trade names Luzu, Lulicon) is an imidazole antifungal drug. As a 1% topical cream, It is indicated for the treatment of athlete's foot, jock itch, and ringworm caused by dermatophytes such as Trichophyton rubrum, Microsporum gypseum[2] and Epidermophyton floccosum.[1]
References
- 1 2 "LUZU (luliconazole) Cream, 1%. Full Prescribing Information." (PDF). Valeant Pharmaceuticals North America LLC. Retrieved 1 October 2015.
- ↑ "FDA approves luliconazole for tinea pedis". November 19, 2013. Retrieved 14 January 2014.
External links
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.